Blocking of leukocyte accumulation in the cerebrospinal fluid augments bacteremia and increases lethality in experimental pneumococcal meningitis
Introduction
Bacterial meningitis is characterized by an inflammatory response, altered blood brain barrier function and brain damage caused by an invading pathogen within the subarachnoidal space. Whilst the exact mechanisms responsible for these changes are not fully understood, leukocyte infiltration observed in damaged brain tissue, obtained from autopsies of patients with bacterial meningitis or from experimental studies, suggests that leukocytes are involved in the pathogenesis of vasculitis, thrombophlebitis and brain damage (Cairns and Russel, 1946, Quaade and Kristensen, 1962, Pfister et al., 1992, Tuomanen et al., 1989, Zysk et al., 1996). Therefore, attenuation of the inflammatory response has been a primary target in attempts to improve the outcome of bacterial meningitis. Recently, the demonstration of a survival advantage with the use of dexamethasone in a clinical study of bacterial meningitis has indicated the beneficial effect of an anti-inflammatory approach (de Gans and van de Beek, 2002). Indeed the blocking of leukocyte entry into the brain has previously been shown to reduce indices of blood–brain-barrier breakdown (Saez-Llorens et al., 1991, Ostergaard et al., 2000, Tuomanen et al., 1989), and to reduce formation of brain oedema in experimental meningitis models (Tuomanen et al., 1989, Saez-Llorens et al., 1991, Angstwurm et al., 1995, Weber et al., 1995, Weber et al., 1997). In experimental models of stroke leukocyte blocking has been shown to attenuate development of brain damage due to reperfusion injury (Prestigiacomo et al., 1999). However, the extrapolation of these results to a potential effect on mortality, outcome and development of brain damage still remain to be clarified.
The primary aim of this study was therefore to investigate the influence of a reduced leukocyte response in the central nervous system on outcome and brain pathology in an experimental model of pneumococcal meningitis in rats. The selectin blocker fucoidin was used to block leukocyte entry into the cerebrospinal fluid (CSF) since it has previously been shown to efficiently inhibit leukocyte accumulation in the CSF in experimental meningitis in rabbits (Granert et al., 1994, Granert et al., 1998, Granert et al., 1999, Ostergaard et al., 2000).
Section snippets
Experimental pneumococcal meningitis
The experimental protocol was approved by the Danish Animal Inspectorate (Dyreforsoegstilsynet). Young adult male Wistar rats (180–200 g) were used for the meningitis experiments. Normal day/night cycles and free access to food and water were provided.
Experimental study design
A total of 125 rats were assigned to the trials. A total of 108 rats were inoculated with a bacterial suspension and randomly assigned to receive fucoidin 3 times daily from the time of infection (fucoidin pre-treated group, n = 70) or merely
Effect of pre-treatment with fucoidin on WBC and bacterial counts in CSF and blood 24 h after bacterial inoculation (Table 1)
WBC counts in CSF were significantly reduced in fucoidin pre-treated rats compared to controls (p = 0.01) whereas no difference in the WBC counts in blood was observed between the two groups (p = 0.55) (Table 1).
Bacterial counts in CSF were unaffected by pre-treatment with fucoidin (p = 0.54). A significant increase in blood bacterial counts was found among fucoidin pre-treated rats compared to controls (p = 0.03).
Effect of pre-treatment with fucoidin on fatal outcome and sequelae (Table 1 and Fig. 1)
The risk of developing terminal illness was increased in the group pre-treated with
Discussion
Our results demonstrate that the blocking of leukocyte influx into the cerebral compartment increased the risk of a fatal outcome from pneumococcal meningitis, suggesting that migration of leucocytes from the blood compartment is an important component of the host response to bacteria in the CSF. This is consistent with data acquired from other models of infection (e.g. arthritis, sepsis, meningitis) where increased mortality is found in animals with a genetically or medically attenuated
Acknowledgements
Financial support from the following foundations is gratefully acknowledged: Den Lægevidenskabelige Forskningsfond for Storkøbenhavn, Færøerne og Grønland; Eivind Eckbos dansk-norske Legat; Lily Benthine Lunds Fond; Christian Larsen og Dommer Ellen Larsens Legat; Direktør Jacob Madsen og Hustru Olga Madsens Fond; Fonden til Lægevidenskabens Fremme and H:S Fondet. The authors would also like to thank Jesper Madsen for statistical support, Dr. Ian Rowland for help in preparing the manuscript and
References (31)
- et al.
Fucoidin, a polysaccharide inhibiting leukocyte rolling, attenuates inflammatory responses in experimental pneumococcal meningitis in rats
Neurosci. Lett.
(1995) - et al.
Increased mortality and spatial memory deficits in TNF-alpha-deficient mice in ceftriaxone-treated experimental pneumococcal meningitis
Neurobiol. Dis.
(2004) - et al.
Ligands of macrophage scavenger receptor induce cytokine expression via differential modulation of protein kinase signaling pathways
J. Biol. Chem.
(2001) - et al.
Attenuation of the bacterial load in blood by pretreatment with granulocyte-colony-stimulating factor protects rats from fatal outcome and brain damage during Streptococcus pneumoniae meningitis
Infect. Immun.
(2004) - et al.
Cerebral arteritis and phlebitis in pneumococcal meningitis
J. Pathol. Bacteriol.
(1946) - et al.
Dexamethasone in adults with bacterial meningitis
N. Engl. J. Med.
(2002) - et al.
Experimental pneumococcal meningitis: role of leukocytes in pathogenesis
Infect. Immun.
(1983) - et al.
Inhibition of leukocyte rolling with polysaccharide fucoidin prevents pleocytosis in experimental meningitis in the rabbit
J. Clin. Invest.
(1994) - et al.
The polysaccharide fucoidin inhibits the antibiotic-induced inflammatory cascade in experimental pneumococcal meningitis
Clin. Diagn. Lab. Immunol.
(1998) - et al.
Effects of polysaccharide fucoidin on cerebrospinal fluid interleukin-1 and tumor necrosis factor alpha in pneumococcal meningitis in the rabbit
Infect. Immun.
(1999)